AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Oncology Today with Dr Neil Love
00:00
When and Whom to Test for PTEN Loss
Daniel George recommends PTEN testing particularly for high-risk or metastatic patients, noting IHC scalability.
Play episode from 23:03
Transcript
